Blanket purchase agreement for A1C hemoglobin testing for VISN 23.

Ended Awarded Last action

Contract number
36C26325N0032
Awardee
Awarding agency
Obligated
$13,593

Award facts

Opportunity
  • 36C26324AP4378 Solicitation number
Contract value 100% obligated
$13,592.64 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
50 Sheridan St, FORT MEADE, SD 57741, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 -$6,567
Original award $20,160

About this award

The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23), awarded a Blanket Purchase Agreement (BPA) call valued at $13,592.64 to Tosoh Bioscience, Inc. (doing business as Tosoh USA) on October 1, 2024, for hemoglobin A1C testing supplies and services. The contract, which extends through September 30, 2025, is issued under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III) and carries no small business set-aside designation. Tosoh Bioscience, a South San Francisco-based manufacturer specializing in high-performance liquid chromatography testing products and hemoglobin analyzers, will provide A1C testing instrumentation, reagents, test cartridges, and related clinical diagnostic supplies to support diabetes diagnosis and management across VA medical facilities in the VISN 23 region. Performance of work will occur at the Fort Meade, South Dakota location.

This award represents a task order call against Tosoh Bioscience's larger BPA vehicles with VISN 23, which include a $2.5 million indefinite delivery contract for A1C hemoglobin testing products and services and a $650,000 BPA for hemoglobin analyzers on a cost-per-reportable-result basis. The contract supports the VA's clinical laboratory operations and veteran healthcare delivery by ensuring access to advanced diagnostic testing capabilities. As the prime contractor on this award, Tosoh Bioscience operates without subcontractor involvement and maintains an extensive portfolio of approximately $10.6 million in federal contract vehicles across multiple VA networks and the Defense Health Agency, establishing the company as a key provider of specialized hemoglobin A1C testing solutions to federal healthcare agencies.

Quick answers

Who was awarded contract 36C26325N0032?

36C26325N0032 was awarded to Tosoh Bioscience, Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on October 1, 2024.

How much is contract 36C26325N0032 worth?

The government has obligated $13,593 on 36C26325N0032.

Is contract 36C26325N0032 an order under another contract?

Yes. 36C26325N0032 is a BPA call under V797D40130-36C26325A0001, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract 36C26325N0032 competed?

The extent of competition for 36C26325N0032 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award